Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (201-210 of 392) with videos related to

Pageof 40
Sort By:
Journal of the National Cancer Institute|December 11, 2008
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemiaNicolas Pottier, Wenjian Yang, Mahfoud Assem, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2022
Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortalityArdine M J Reedijk, Auke Beishuizen, Jan Willem W Coebergh, et al.
Blood|December 25, 2009
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infantsRonald W Stam, Pauline Schneider, Jill A P Hagelstein, et al.
Haematologica|December 18, 2009
Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemiaMariël L te Winkel, Robert D van Beek, Sabine M P F de Muinck Keizer-Schrama, et al.
Scientific Reports|March 16, 2019
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Judith M Boer, Alex Q Hoogkamer, et al.
Cancer Cell|October 3, 2006
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistanceGuo Wei, David Twomey, Justin Lamb, et al.
Leukemia|September 10, 2024
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?Janine Stutterheim, Rachella van der Waarden, Hester A de Groot-Kruseman, et al.
Blood|October 31, 2002
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L den Boer, Jules P P Meijerink, et al.
Leukemia Research|November 6, 2010
Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment compositionCornelis M van Tilburg, Vincent H J van der Velden, Elisabeth A M Sanders, et al.
Haematologica|May 25, 2010
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemiaDiana Schotte, Ellen A M Lange-Turenhout, Dominique J P M Stumpel, et al.
Pageof 40

Showing results (201-210 of 392) with videos related to

Sort By:
Pageof 40
Journal of the National Cancer Institute|December 11, 2008
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemiaNicolas Pottier, Wenjian Yang, Mahfoud Assem, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2022
Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortalityArdine M J Reedijk, Auke Beishuizen, Jan Willem W Coebergh, et al.
Blood|December 25, 2009
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infantsRonald W Stam, Pauline Schneider, Jill A P Hagelstein, et al.
Haematologica|December 18, 2009
Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemiaMariël L te Winkel, Robert D van Beek, Sabine M P F de Muinck Keizer-Schrama, et al.
Scientific Reports|March 16, 2019
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Judith M Boer, Alex Q Hoogkamer, et al.
Cancer Cell|October 3, 2006
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistanceGuo Wei, David Twomey, Justin Lamb, et al.
Leukemia|September 10, 2024
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?Janine Stutterheim, Rachella van der Waarden, Hester A de Groot-Kruseman, et al.
Blood|October 31, 2002
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L den Boer, Jules P P Meijerink, et al.
Leukemia Research|November 6, 2010
Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment compositionCornelis M van Tilburg, Vincent H J van der Velden, Elisabeth A M Sanders, et al.
Haematologica|May 25, 2010
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemiaDiana Schotte, Ellen A M Lange-Turenhout, Dominique J P M Stumpel, et al.
Pageof 40